{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:24:37Z","timestamp":1766467477999,"version":"build-2065373602"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,11]]},"DOI":"10.7759\/cureus.94355","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:25:36Z","timestamp":1760207136000},"source":"Crossref","is-referenced-by-count":1,"title":["Life-Threatening Anaphylaxis Following Intravenous Ondansetron in a Previously Healthy Woman: A Case Report"],"prefix":"10.7759","author":[{"given":"Md. Aziz","family":"Mazumdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaneez","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Midha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Ondansetron. Drugs. BNF content published by NICE. (n.d). Accessed. August 22, 2025: https:\/\/bnf.nice.org.uk\/drugs\/ondansetron\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000132","article-title":"Ondansetron and probiotics in the management of pediatric acute gastroenteritis in developed countries","volume":"31","author":"Schnadower D","year":"2015","unstructured":"Schnadower D, Finkelstein Y, Freedman SB. Ondansetron and probiotics in the management of pediatric acute gastroenteritis in developed countries. Curr Opin Gastroenterol. 2015, 31:1-6. 10.1097\/MOG.0000000000000132","journal-title":"Curr Opin Gastroenterol"},{"key":"ref3","unstructured":"Ondansetron (monograph). Drugs.Com. (n.d). Accessed. August 22, 2025: https:\/\/www.drugs.com\/monograph\/ondansetron.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6363","article-title":"Hypersensitivity reaction to intravenous ondansetron: a\u00a0case report","volume":"10","author":"Devkota S","year":"2022","unstructured":"Devkota S, Pradhan U, Gajurel I. Hypersensitivity reaction to intravenous ondansetron: a\u00a0case report. Clin Case Rep. 2022, 10:e06363. 10.1002\/ccr3.6363","journal-title":"Clin Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181ea214a","article-title":"Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report","volume":"32","author":"Demir HA","year":"2010","unstructured":"Demir HA, Batu ED, Yal\u00e7\u0131n B, Civelek E, Sa\u00e7kesen C, B\u00fcy\u00fckpamuk\u00e7u M. Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report. J Pediatr Hematol Oncol. 2010, 32:e341-2. 10.1097\/MPH.0b013e3181ea214a","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons FE","year":"2015","unstructured":"Simons FE, Ebisawa M, Sanchez-Borges M, et al.. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015, 8:32. 10.1186\/s40413-015-0080-1","journal-title":"World Allergy Organ J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-2-274","article-title":"Hypersensitivity to intravenous ondansetron: a case report","volume":"2","author":"Mehra KK","year":"2008","unstructured":"Mehra KK, Gogtay NJ, Ainchwar R, Bichile LS. Hypersensitivity to intravenous ondansetron: a case report. J Med Case Rep. 2008, 2:274. 10.1186\/1752-1947-2-274","journal-title":"J Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2011.02124.x","article-title":"Anaphylaxis to an ondansetron wafer","volume":"48","author":"Tan J","year":"2012","unstructured":"Tan J, Mehr S. Anaphylaxis to an ondansetron wafer. J Paediatr Child Health. 2012, 48:543-4. 10.1111\/j.1440-1754.2011.02124.x","journal-title":"J Paediatr Child Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4110","article-title":"Fatal anaphylaxis to intravenous ondansetron: a case report","volume":"9","author":"Sapkota K","year":"2021","unstructured":"Sapkota K, Bhagat R. Fatal anaphylaxis to intravenous ondansetron: a case report. Clin Case Rep. 2021, 9:e04110. 10.1002\/ccr3.4110","journal-title":"Clin Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42894","article-title":"Ondansetron-induced anaphylactic shock: an in-depth analysis of a rare adverse event","volume":"15","author":"Suzuki Y","year":"2023","unstructured":"Suzuki Y, Liu S, Iwata M, Yamamoto H, Nishida K. Ondansetron-induced anaphylactic shock: an in-depth analysis of a rare adverse event. Cureus. 2023, 15:e42894. 10.7759\/cureus.42894","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen376","article-title":"Ondansetron anaphylaxis: a case report and protocol for skin testing","volume":"102","author":"Fernando SL","year":"2009","unstructured":"Fernando SL, Broadfoot AJ. Ondansetron anaphylaxis: a case report and protocol for skin testing. Br J Anaesth. 2009, 102:285-6. 10.1093\/bja\/aen376","journal-title":"Br J Anaesth"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15761\/IMM.1000273","article-title":"Delayed anaphylactic reaction to intravenous infusion of ondansetron report of 3 cases","volume":"4","author":"Nesrine BS","year":"2017","unstructured":"Nesrine BS, Haifa R, Bouraoui EO, et al.. Delayed anaphylactic reaction to intravenous infusion of ondansetron report of 3 cases. Integr Mol Med. 2017, 4:10.15761\/IMM.1000273","journal-title":"Integr Mol Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/400398-life-threatening-anaphylaxis-following-intravenous-ondansetron-in-a-previously-healthy-woman-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:25:37Z","timestamp":1760207137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/400398-life-threatening-anaphylaxis-following-intravenous-ondansetron-in-a-previously-healthy-woman-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.94355","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,11]]}}}